EROSIVE ESOPHAGITIS
Clinical trials for EROSIVE ESOPHAGITIS explained in plain language.
Never miss a new study
Get alerted when new EROSIVE ESOPHAGITIS trials appear
Sign up with your email to follow new studies for EROSIVE ESOPHAGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New acid reflux drug shows promise in large trial
Disease control CompletedThis study tested a new medication called BLI5100 in 1250 adults with erosive esophagitis, a condition where stomach acid damages the esophagus. The goal was to see if BLI5100 could heal the damage within 8 weeks and keep it healed for 24 weeks, compared to a standard acid-reduci…
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
New GERD drug shows safety over one year in large trial
Disease control CompletedThis study tested the safety of a daily medication called BLI5100 in 400 adults with gastroesophageal reflux disease (GERD), including those with non-erosive reflux disease or healed erosive esophagitis. Participants took the drug once daily for up to 52 weeks. The main goal was …
Matched conditions: EROSIVE ESOPHAGITIS
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated May 22, 2026 13:51 UTC